68 Stocks Moving In Wednesday's Mid-Day Session

Gainers

• Myomo, Inc. MYO shares climbed 118% to $28.31. Myomo shares surged around 115% on Tuesday after the company's MyoPro was approved for reimbursement by German health insurer BARMER.
• Predictive Oncology Inc. POAI gained 54.4% to $4.20. Predictive Oncology launched innovative specialty media for growing ovarian tumors in the lab.
• VIVUS, Inc. VVUS shares surged 47.2% to $3.3850 after the company received FDA approval for improved formulation of PANCREAZE with a 36-month shelf life.
• Puma Biotechnology, Inc. PBYI shares rose 29.2% to $13.67. Shares of several healthcare companies are trading higher as unconfirmed reported of progress towards a coronavirus treatment raise investor sentiment amid the virus outbreak. However, the WHO played down these reports and said there are no known treatments.
• SenesTech Inc SNES shares gained 26% to $8.40.
• Greenhill & Co., Inc. GHL shares climbed 25.7% to $20.92 following better-than-expected Q4 results.
• Peabody Energy Corporation BTU shares rose 25.6% to $9.29 after the company reported upbeat Q4 sales and disclosed a deal with Elliott Mgmt.
• Moleculin Biotech, Inc. MBRX shares gained 21.6% to $1.07. WPD Pharmaceuticals’ Annamycin drug received FDA approval of Fast Track designation.
• USANA Health Sciences, Inc. USNA shares rose 19% to $78.44 following strong Q4 results.
• Nautilus, Inc. NLS climbed 18.9% to $3.21 after announcing a new $70,000,000 credit facility.
• Modine Manufacturing Company MOD gained 17.1% to $9.17 after reporting upbeat Q3 earnings.
• U.S. Silica Holdings, Inc. SLCA shares surged 15.9% to $5.36 as markets gain momentum amid optimism regarding a potential coronavirus treatment.
• BioXcel Therapeutics, Inc. BTAI gained 14.9% to $19.93 after the company announced FDA clearance of IND application for BXCL501 for the treatment of opioid withdrawal symptoms.
• CONSOL Energy Inc. CEIX surged 14.7% to $9.36.
• Coty Inc COTY rose 14.6% to $12.19 following upbeat Q2 results.
• Arbutus Biopharma Corporation ABUS rose 14.1% to $3.2050. JMP Securities upgraded Arbutus Biopharma from Market Perform to Market Outperform.
• O-I Glass, Inc. OI gained 13.8% to $15.25 after the company reported better-than-expected Q4 EPS results.
• Menlo Therapeutics Inc. MNLO surged 13.1% to $5.26. Menlo Therapeutics reported publication of Phase 2 results for serlopitant for treatment of pruritus associated with psoriasis in the 'Journal Of American Academy Of Dermatology.'
• Onconova Therapeutics, Inc. ONTX rose 12.4% to $0.4215 after surging 19.02% on Tuesday.
• Amyris, Inc. AMRS gained 12.2% to $3.2766.
• SandRidge Energy, Inc. SD climbed 12% to $2.90.
• Savara Inc. SVRA rose 11.6% to $2.50.
• Montage Resources Corporation MR shares gained 11% to $3.72.
• Owens & Minor, Inc. OMI shares rose 10.9% to $6.19.
• Nabors Industries Ltd. NBR surged 10.7% to $2.27.
• Vista Outdoor Inc. VSTO shares rose 10.7% to $8.34.
• Conn's, Inc. CONN surged 10.7% to $9.09.
• Oasis Petroleum Inc. OAS surged 10.1% to $2.4450 as markets gain momentum amid optimism regarding a potential coronavirus treatment.
• California Resources Corporation CRC shares gained 10% to $7.62.
• YRC Worldwide Inc. YRCW shares gained 9.8% to $2.80 following strong Q4 results.
• Iteris, Inc. ITI climbed 9.8% to $5.62 following strong Q3 sales.
• Centennial Resource Development, Inc. CDEV gained 8.9% to $3.19..
• Tata Motors Limited TTM rose 8.8% to $12.76 on a continued rebound amid coronavirus fears.
• Capri Holdings Limited CPRI gained 8.8% to $33.45 after the company reported better-than-expected Q3 EPS and sales results.
• Valaris plc VAL shares rose 7.9% to $5.68.
• Cerner Corporation CERN climbed 6.5% to $79.04 after the company reported better-than-expected Q4 EPS and sales results. Following earnings, Baird maintained an Outperform rating and raised the price target from $72 to $85.
• QIAGEN N.V. QGEN rose 6.5% to $35.33 after reporting upbeat Q4 results.
• TherapeuticsMD Inc TXMD surged 6.5% to $2.46 on a rebound amid coronavirus fears.
• Unum Group UNM rose 6.4% to $29.42 after the company reported better-than-expected Q4 EPS and sales results.
• Humana Inc HUM rose 5.4% to $361.17 after the company reported better-than-expected Q4 EPS and sales results.
• Microchip Technology Inc. MCHP climbed 5.4% to $107.14 after the company reported better-than-expected Q3 EPS and sales results.
• Chubb Ltd CB gained 4.9% to $161.73 after the company reported better-than-expected Q4 results.
• Aimmune Therapeutics Inc AIMT surged 4.1% to $30.57 after the company reported that it added $200 million of equity investment by Nestle. The company also announced it will license its exclusive global rights to Xencor's XmAb 7195 for the development of Next-Gen food allergy treatment.

Check out these big penny stock gainers and losers

Losers

• Plantronics, Inc. PLT shares dipped 37.7% to $16.75 after the company reported worse-than-expected Q3 sales results. Evercore ISI Group downgraded Plantronics from Outperform to In-Line and lowered the price target from $37 to $21.
• LMP Automotive Holdings, Inc. LMPX shares fell 32.5% to $25.00. LMP Automotive expects preliminary Q4 sales of $3.03 million and EPS of $(0.08).
• Nano Dimension Ltd. NNDM dipped 22% to $1.4908. Nano Dimension priced 2.3 million ADS public offering at $1.50 per ADS.
• PC Connection, Inc. CNXN fell 21.3% to $41.40 after reporting weak Q4 sales.
• Knowles Corporation KN dropped 18.6% to $16.57 after the company reported worse-than-expected Q4 EPS and sales results. The company also issued Q1 EPS and sales guidance below estimates.
• PDS Biotechnology Corporation PDSB dipped 14.2% to $2.1115.
• ZIOPHARM Oncology Inc. ZIOP shares fell 14% to $3.50 after the company priced 27.83 million share offering at $3.25 per share.
• Phio Pharmaceuticals Corp PHIO shares tumbled 13.3% to $8.24. Phio Pharma reported a $1.74 million registered direct offering priced at the market.
• Tesla, Inc. TSLA fell 13.1% to $770.50 after days of upward momentum. The company reportedly suggested it will delay February delivery of some China-made Model 3 vehicles. Additionally, Canaccord Genuity downgraded the stock to Hold.
• Manhattan Associates, Inc. MANH dropped 11.8% to $78.47 following Q4 results.
• Boot Barn Holdings Inc BOOT declined 11.7% to $37.30 after the company reported worse-than-expected Q3 EPS results.
• Stereotaxis, Inc. STXS dropped 11.5% to $3.79.
• NanoViricides, Inc. NNVC fell 10.5% to $9.07 after declining 6.38% on Tuesday.
• Bill.com Holdings, Inc. BILL shares declined 10.2% to $47.50.
• Ford Motor Company F dropped 9.9% to $8.27 after the company reported worse-than-expected Q4 EPS results.
• Snap Inc SNAP tumbled 9.8% to $17.13 after the company reported worse-than-expected Q4 sales results.
• ScanSource, Inc. SCSC dipped 9.6% to $32.35 following downbeat quarterly earnings.
• Afya Limited AFYA dropped 9% to $27.43. Afya launched proposed public offering of 11.521 million shares of common by selling shareholders.
• M/I Homes, Inc. MHO shares declined 8.8% to $40.26 after the company reported downbeat Q4 results.
• New Relic Inc NEWR shares fell 8% to $65.14 after the company reported worse-than-expected Q3 EPS results. The company also issued Q4 & FY20 EPS guidance below analyst estimates.
• SolarWinds Corporation SWI shares declined 7.6% to $19.50 following weak quarterly sales.
• Seagate Technology PLC STX dropped 7.3% to $54.65 after the company reported worse-than-expected Q2 sales results. Summit Insight Group also downgraded the company from Hold to Sell.
• Genworth Financial Inc GNW dipped 7% to $3.8250 after the company reported worse-than-expected Q4 EPS results.
• Match Group Inc MTCH fell 6.1% to $77.86 after the company reported worse-than-expected Q4 sales results. The company also issued Q1 sales guidance below estimates.
• Take-Two Interactive Software, Inc. TTWO fell 4.5% to $121.29 after the company announced Vice President Dan Houser will leave the company in March.